Penumbra (NYSE:PEN – Get Free Report) and Sensus Healthcare (NASDAQ:SRTS – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, dividends, analyst recommendations, earnings, institutional ownership, risk and valuation. Insider & Institutional Ownership 88.2% of Penumbra shares are […]
Penumbra, Inc. (NYSE:PEN – Get Free Report) Director Harpreet Grewal sold 170 shares of the business’s stock in a transaction dated Monday, October 2nd. The stock was sold at an average price of $240.99, for a total value of $40,968.30. Following the completion of the sale, the director now owns 9,150 shares in the company, […]
/PRNewswire/ Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the third quarter 2023 after.
Penumbra (NYSE:PEN – Get Free Report) had its price objective dropped by investment analysts at Citigroup from $390.00 to $320.00 in a research report issued to clients and investors on Monday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. Citigroup’s price objective indicates a potential upside of 35.08% from the company’s […]